The risk factors of Ventilator Associated Pneumonia and relationship with type of tracheostomy
Trends in Anaesthesia and Critical Care, cilt.35, ss.38-43, 2020 (ESCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 35
- Basım Tarihi: 2020
- Doi Numarası: 10.1016/j.tacc.2020.06.010
- Dergi Adı: Trends in Anaesthesia and Critical Care
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, EMBASE
- Sayfa Sayıları: ss.38-43
- Anahtar Kelimeler: Ventilator associated pneumonia, Percutaneous dilatational tracheostomy, Surgical tracheostomy, Mortality, Intensive care unit
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Objectives: Ventilator associated pneumonia (VAP); is a hospital-acquired pneumonia that develops 48–72 h after intubation without pneumonia during intubation. Primarily aim of this study was investigated the effects of the timing of tracheostomy on the development of VAP. Secondary outcome was analyzed the risk factors affecting VAP in ICU. Methods: Patients aged 18 and over who were followed-up for more than 48 h on mechanical ventilation in the ICU were included in this retrospective study. Duration of mechanical ventilation, days on endotracheal intubation until tracheostomy, technique of tracheostomy, and the day that VAP diagnosed and the prognosis were recorded. Results: A total of 296 patients treated with tracheostomy were included in the study, 124 (41.9%) were female and 172 (58.1%) were male. Mean MV duration was 9.6 ± 28.5 days, and mean length of ICU stay was 18.0 ± 37.5 days. Sixty-two (55.9%) patients underwent surgical tracheostomy and 49 (44.1%) underwent percutaneous tracheostomy. VAP was significantly higher in the tracheostomy group (p < 0.001). Conclusion: VAP is a preventable infectious disease with a high mortality and morbidity. Patients with risk factors associated with VAP should be assessed and measures should be implemented to reduce VAP development.